COVID-19对癌症患者的影响
Demi Wekking1, Thilini H Senevirathne2, Josie L Pearce3
1Amsterdam UMC, Location Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Cytokine & growth factor reviews
|December 16, 2023
概括
癌症患者对COVID-19疫苗的免疫反应较弱,特别是对新变种的免疫反应. 对这个脆弱群体来说,增强剂注射至关重要,以提高对严重的SARS-CoV-2感染的保护.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
背景情况:
- 癌症患者对严重的COVID-19非常敏感,增加了发病和死亡风险.
- 晚年,吸烟,晚期疾病,化疗和ECOG评分≥2是关键的死亡风险因素.
- 在癌症患者中,COVID-19疫苗显示免疫反应效率降低,特别是那些患有血液性恶性瘤的人.
研究的目的:
- 审查COVID-19疫苗在癌症患者的有效性,包括那些接受HCT或CAR T细胞治疗的人.
- 在这个人群中探索对SARS-CoV-2疫苗接种的幽默和细胞免疫反应.
- 为了确定严重感染和低于最佳的疫苗反应的风险因素和生物标志物.
主要方法:
- 对癌症患者COVID-19疫苗接种研究的文献综述.
- 对幽默性 (抗体) 和细胞 (T细胞) 免疫反应的分析.
- 检查与感染严重程度和疫苗反应相关的风险因素和生物标志物.
主要成果:
- 在癌症患者中,疫苗诱导的免疫反应往往降低,与较低的中和抗体水平对关心的变体.
- 免疫力随着时间的推移而减弱,因此需要进行补充疫苗接种以获得持续的保护.
- 引起关注的病毒变体 (VOCs) 由于疫苗有效性降低,存在持续的挑战.
结论:
- 了解癌症患者对COVID-19疫苗的免疫反应对于公共卫生战略至关重要.
- 推给这个脆弱人群进行补充疫苗接种,以加强保护.
- 需要进一步研究生物标志物和改进疫苗接种策略,以优化癌症患者的SARS-CoV-2保护.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
292
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
182
相关概念视频
Cancer Survival Analysis
355
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
355
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
What is Cancer?
10.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Vaccines
376
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
376
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
